Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fexofenadine HCl for Cat Allergy Symptoms
NCT00637884Phase 4Completed
- Sponsor
- Sanofi
- Start
- Nov 2003
- Modality
- Small Molecules
01
Overview
A Phase 4 trial of fexofenadine in allergic rhinitis (AR), sponsored by Sanofi. Started Nov 2003; status: completed.
02
Drugs
fexofenadine
03
Conditions
allergic rhinitis (AR)
Beyond the preview
Go deeper on NCT00637884.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00637884.